Aries Wealth Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.67M | Sell |
3,165
-24
| -0.8% | -$13.5K | 0.33% | 63 |
|
|
2026
Q1 | $1.79M | Buy |
3,189
+12
| +0.4% | +$7.7K | 0.39% | 59 |
|
|
2025
Q4 | $2.15M | Sell |
3,177
-71
| -2% | -$48.4K | 0.48% | 52 |
|
|
2025
Q3 | $2.08M | Buy |
3,248
+76
| +2% | +$46.1K | 0.49% | 51 |
|
|
2025
Q2 | $1.7M | Buy |
3,172
+76
| +2% | +$36.3K | 0.44% | 56 |
|
|
2025
Q1 | $1.3M | Buy |
3,096
+168
| +6% | +$72.9K | 0.35% | 71 |
|
|
2024
Q4 | $1.21M | Sell |
2,928
-9
| -0.3% | -$3.95K | 0.33% | 73 |
|
|
2024
Q3 | $1.48M | Sell |
2,937
-68
| -2% | -$33K | 0.41% | 60 |
|
|
2024
Q2 | $1.46M | Buy |
3,005
+77
| +3% | +$38.7K | 0.46% | 55 |
|
|
2024
Q1 | $1.58M | Buy |
2,928
+70
| +2% | +$38.3K | 0.51% | 52 |
|
|
2023
Q4 | $1.59M | Buy |
2,858
+220
| +8% | +$103K | 0.57% | 49 |
|
|
2023
Q3 | $1.13M | Buy |
2,638
+31
| +1% | +$15.5K | 0.44% | 62 |
|
|
2023
Q2 | $1.31M | Buy |
2,607
+151
| +6% | +$72.4K | 0.51% | 56 |
|
|
2023
Q1 | $1.23M | Buy |
2,456
+56
| +2% | +$26.8K | 0.5% | 60 |
|
|
2022
Q4 | $979K | Buy |
2,400
+563
| +31% | +$219K | 0.42% | 67 |
|
|
2022
Q3 | $661K | Buy |
1,837
+837
| +84% | +$307K | 0.29% | 83 |
|
|
2022
Q2 | $351K | Buy |
+1,000
| New | +$408K | 0.16% | 119 |
|
|
2022
Q1 | – | Sell |
-1,000
| Closed | -$658K | – | 138 |
|
|
2021
Q4 | $658K | Hold |
1,000
| – | – | 0.25% | 90 |
|
|
2021
Q3 | $622K | Hold |
1,000
| – | – | 0.26% | 90 |
|
|
2021
Q2 | $632K | Hold |
1,000
| – | – | 0.27% | 88 |
|
|
2021
Q1 | $514K | Hold |
1,000
| – | – | 0.23% | 93 |
|
|
2020
Q4 | $513K | Hold |
1,000
| – | – | 0.26% | 88 |
|
|
2020
Q3 | $393K | Hold |
1,000
| – | – | 0.22% | 96 |
|
|
2020
Q2 | $330K | Sell |
1,000
-500
| -33% | -$145K | 0.2% | 101 |
|
|
2020
Q1 | $360K | Hold |
1,500
| – | – | 0.27% | 81 |
|
|
2019
Q4 | $400K | Hold |
1,500
| – | – | 0.24% | 97 |
|
|
2019
Q3 | $415K | Hold |
1,500
| – | – | 0.28% | 88 |
|
|
2019
Q2 | $418K | Sell |
1,500
-8
| -0.5% | -$1.97K | 0.29% | 90 |
|
|
2019
Q1 | $337K | Buy |
1,508
+8
| +0.5% | +$1.65K | 0.25% | 93 |
|
|
2018
Q4 | $279K | Hold |
1,500
| – | – | 0.3% | 86 |
|
|
2018
Q3 | $374K | Buy |
1,500
+100
| +7% | +$24.3K | 0.34% | 75 |
|
|
2018
Q2 | $343K | Hold |
1,400
| – | – | 0.32% | 82 |
|
|
2018
Q1 | $271K | Hold |
1,400
| – | – | 0.26% | 96 |
|
|
2017
Q4 | $253K | Buy |
+1,400
| New | +$220K | 0.23% | 98 |
|
Other funds holding IDXX
Aries Wealth Management's IDXX Position: Q2 2026 in Review
Aries Wealth Management reduced its Idexx Laboratories (IDXX) stake by 0.75% in Q2 2026, selling an estimated $13.5K and leaving 3,165 shares worth $1.67M. The position accounts for 0.33% of the portfolio, ranked #63.
Aries Wealth Management first reported a position in IDXX in Q4 2017 and has held it in 34 quarters since. The position peaked at $2.15M in Q4 2025. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Aries Wealth Management held 3,165 shares of Idexx Laboratories worth $1.67M as of Q2 2026.
- Aries Wealth Management sold 24 Idexx Laboratories shares in Q2 2026, an estimated $13.5K.
- Idexx Laboratories made up 0.33% of Aries Wealth Management's portfolio in Q2 2026, its #63 holding.
- Aries Wealth Management first reported a position in Idexx Laboratories in Q4 2017 and has held it in 34 quarters since.
- Aries Wealth Management's Idexx Laboratories position peaked at $2.15M in Q4 2025.
- 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Aries Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.